HEM Pharma Inc. (KOSDAQ:376270)
South Korea · Delayed Price · Currency is KRW 79,900
-600 (-0.75%)
At close: Feb 27, 2026
HEM Pharma Market Cap
HEM Pharma has a market cap or net worth of 573.02 billion as of February 27, 2026. Its market cap has increased by 351.74% in one year.
Market Cap
573.02B
Enterprise Value
580.51B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
79,900.00
Market Cap Chart
Since November 5, 2024, HEM Pharma's market cap has increased from 114.18B to 573.02B, an increase of 401.87%. That is a compound annual growth rate of 241.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 573.02B | 74.97% |
| Dec 30, 2025 | 327.49B | 185.09% |
| Dec 30, 2024 | 114.87B | 0.61% |
| Nov 5, 2024 | 114.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G2GBIO | 1.78T |
| Myung In Pharmaceutical LTD. | 966.52B |
| Samyang Biopharm | 722.02B |
| ImmuneOncia Therapeutics | 620.76B |
| CellBion | 355.43B |
| DAE HWA Pharmaceutical | 291.48B |
| NOVAREX | 244.82B |
| OPTUS Pharmaceutical | 207.88B |